Michael M. Kitt

Combined Accelerated Tissue-Plasminogen Activator and Platelet Glycoprotein IIb/IIIa Integrin Receptor Blockade With Integrilin in Acute Myocardial Infarction

E. Magnus Ohman, Neal S. Kleiman, Gerald M. Gacioch et al. · Circulation · 1997 · 381 citations

Medicine, Pharmacology, Pharmacotherapy +17

Telavancin Versus Vancomycin for the Treatment of Complicated Skin and Skin‐Structure Infections Caused by Gram‐Positive Organisms

Martín E. Stryjewski, Donald R. Graham, Samuel E. Wilson et al. · Clinical Infectious Diseases · 2008 · 289 citations

Pharmacy, Infectious Diseases, Pharmacology +17

Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Platelet Integrin Glycoprotein IIb/IIIa Blocker Integrelin in Elective Coronary Intervention

James E. Tcheng, Robert A. Harrington, Kandice Kottke‐Marchant et al. · Circulation · 1995 · 281 citations

Medicine, Cardiology, Pharmacology +17

Telavancin versus Vancomycin for Hospital-Acquired Pneumonia due to Gram-positive Pathogens

Eric Rubinstein, Tahaniyat Lalani, G. Ralph Corey et al. · Clinical Infectious Diseases · 2010 · 246 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Platelet Glycoprotein IIb/IIIa Integrin Blockade With Eptifibatide in Coronary Stent Intervention

J.Conor O’Shea, Gail E. Hafley, Sally Greenberg et al. · JAMA · 2001 · 231 citations

Medicine, Cardiology, Pharmacotherapy +17